This content is machine translated Migraine prophylaxis Erenumab shows good results compared to topiramate Migraine prophylaxis with CGRP antibodies is characterized above all by a rapid onset of action and good tolerability. A phase IV comparative study evaluated erenumab against the anticonvulsant topiramate in…
View Post 5 min This content is machine translated Pain Congress 2017, Mannheim CGRP receptor antibodies: A hope for migraine patients? The novel CGRP receptor antibody erenumab could usher in a new era in migraine therapy. Initial results from Phase II studies are encouraging.
View Post 3 min This content is machine translated European Academy of Neurology (EAN) in Amsterdam Sexual dysfunction in MS Sexual dysfunction is a “side show” of MS disease. Nevertheless, a considerable proportion of all those affected suffer from it. Not only MS itself, but also the comorbidity “depression” plays…
